Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.

Probiotics, paraprobiotics offer no clear sleep benefits

14 Nov 2020

Currently, there is not enough evidence to support taking probiotics or paraprobiotics to help with subjective or objective sleep quality, reports a new meta-analysis. More studies with better experimental designs are needed to probe the subject further.

From the online databases of PubMed, Web of Science, Scopus, and PsycINFO, 14 studies corresponding to 20 trials were retrieved and deemed eligible for meta-analysis. In the included reports, sleep was assessed using the Pittsburgh Sleep Quality Index (PSQI), electroencephalography (EEG), actigraphy, and subjective patient responses.

A meta-analysis of 11 trials (n=452) found that taking probiotics or paraprobiotics led to an overall significant improvement in PSQI score (mean difference [MD], 0.78, 95 percent confidence interval [CI], 0.395–1.166; p<0.001), with low evidence of heterogeneity. This result was stable to sensitivity analysis, where each trial was removed individually.

In eight trials (n=549), however, the researchers found no significant impact of probiotics or paraprobiotics on subjective ratings of sleep quality (p=0.462). This finding was likewise of low or moderate heterogeneity and remained robust to sensitivity analysis. Similarly, sleep efficiency (six trials; p=0.976) and sleep latency (seven trials; p=0.509) were unaffected by probiotics or paraprobiotics.

Though slight changes in the magnitude of PSQI were observed, the overall principal findings remained unchanged during subgroup analysis.

“While the current evidence suggests that consuming probiotics/paraprobiotics does not significantly influence responses on other subjective sleep scales; nor does it influence sleep efficiency and sleep latency measured objectively using PSG and actigraphy, the number of well-designed research investigations is presently limited,” the researchers said.

“Hence, further research, specifically employing objective sleep outcome measures using well-controlled, within-subject experimental designs, and both homogenous and heterogenous populations are needed,” they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
22 Nov 2020
Mental health comorbidities are common among patients with type 2 diabetes mellitus and may lead to worse outcomes, a recent study has found.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

4 days ago
Vitamin D deficiency may be a contributing factor to the mortality rate among patients with the novel coronavirus disease (COVID-19), reports a new study.
Pearl Toh, 2 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.